Incidence | Deaths | DALYs | |||||||
---|---|---|---|---|---|---|---|---|---|
Number of incident cases, 2019 | Age-standardized incidence rate (per 100,000 population), 2019 | Percentage change in rates, 1990–2019 | Number of deaths, 2019 | Age-standardized death rate (per 100,000 population), 2019 | Percentage change in rates, 1990–2019 | Number of DALYs, 2019 | Age-standardized DALYs rate (per 100,000 population), 2019 | Percentage change in rates, 1990–2019 | |
Global | 1,194,382 | 39.7 | 10.7 | 396,117 | 13.2 | − 21 | 23,491,284 | 782.3 | − 20 |
Female | 685,639 | 45.9 | 9.5 | 202,452 | 13.6 | − 20.9 | 11,973,819 | 804.1 | − 19.9 |
Male | 508,743 | 33.5 | 12 | 193,665 | 12.8 | − 21.2 | 11,517,464 | 760.4 | − 20.2 |
High SDI | 213,165 | 59.6 | 5.2 | 33,370 | 9.2 | − 33.7 | 2,017,829 | 564.4 | − 32 |
High-middle SDI | 301,329 | 53.1 | 30.1 | 76,612 | 13.4 | − 28.4 | 4,515,373 | 801.5 | − 27 |
Middle SDI | 355,636 | 36.9 | 16.5 | 131,819 | 13.7 | − 25.4 | 7,783,143 | 810.2 | − 24.1 |
Low-middle SDI | 207,656 | 29.2 | 16.5 | 100,583 | 14.2 | − 5.1 | 5,968,398 | 836.8 | − 4.8 |
Low SDI | 97,858 | 24.3 | 3.9 | 53,478 | 13.3 | − 3.7 | 3,191,436 | 781.2 | − 3.2 |
Acute lymphoid leukaemia | 38,747 | 1.3 | 66.6 | 11,696 | 0.4 | − 10.6 | 765,511 | 26.1 | − 9.9 |
Acute myeloid leukaemia | 20,183 | 0.7 | 5.6 | 12,166 | 0.4 | − 0.1 | 747,561 | 25.2 | − 0.2 |
Bladder cancer | 14,095 | 0.5 | 29 | 2050 | 0.1 | − 22.6 | 124,475 | 4.1 | − 20.2 |
Brain and central nervous system cancer | 61,511 | 2.1 | 23.9 | 29,105 | 1 | − 6.9 | 1,746,906 | 58.4 | − 6.6 |
Breast cancer | 169,859 | 5.6 | 25.7 | 43,088 | 1.4 | − 4.7 | 2,489,420 | 82.1 | − 2.8 |
Cervical cancer | 119,258 | 3.9 | − 4.2 | 27,168 | 0.9 | − 24.3 | 1,560,541 | 51.4 | − 23.7 |
Chronic lymphoid leukaemia | 4263 | 0.2 | 113.4 | 1010 | 0 | 1.7 | 61,375 | 2.6 | 4.3 |
Chronic myeloid leukaemia | 9203 | 0.3 | − 16 | 4956 | 0.2 | − 33.1 | 294,861 | 9.8 | − 33 |
Colon and rectum cancer | 76,090 | 2.5 | 38.8 | 28,352 | 0.9 | − 2.7 | 1,633,410 | 53.9 | − 2.1 |
Esophageal cancer | 8088 | 0.3 | − 23.9 | 6215 | 0.3 | − 29.7 | 343,752 | 14.5 | − 29.4 |
Gallbladder and biliary tract cancer | 3841 | 0.2 | − 10.5 | 2390 | 0.1 | − 17.1 | 132,562 | 5.6 | − 17 |
Hodgkin lymphoma | 33,388 | 1.1 | − 8.6 | 8093 | 0.3 | − 34.3 | 508,216 | 17.1 | − 33.3 |
Kidney cancer | 21,136 | 0.7 | 62.9 | 4017 | 0.1 | 20.7 | 239,153 | 7.9 | 22.1 |
Larynx cancer | 4214 | 0.2 | − 15.4 | 2250 | 0.1 | − 29.3 | 128,189 | 5.4 | − 28.7 |
Lip and oral cavity cancer | 29,440 | 1 | 29.9 | 10,043 | 0.3 | 19.3 | 580,333 | 19.2 | 19.4 |
Liver cancer | 25,430 | 0.8 | − 50.9 | 18,573 | 0.6 | − 57.5 | 1,046,876 | 34.6 | − 57.1 |
Malignant skin melanoma | 37,266 | 1.2 | 16.3 | 4248 | 0.1 | − 23.9 | 259,089 | 8.6 | − 21.6 |
Mesothelioma | 1466 | 0.1 | − 17.8 | 990 | 0 | − 16.1 | 56,365 | 2.4 | − 16.2 |
Multiple myeloma | 2931 | 0.1 | 35.9 | 1680 | 0.1 | 19 | 95,563 | 4 | 20.3 |
Nasopharynx cancer | 28,562 | 0.9 | 57.8 | 6079 | 0.2 | − 41.9 | 362,911 | 12.1 | − 40.6 |
Non-Hodgkin lymphoma | 52,427 | 1.8 | 20.5 | 20,797 | 0.7 | − 1.5 | 1,275,943 | 42.8 | − 1.1 |
Other leukaemia | 28,811 | 1 | − 47.1 | 15,278 | 0.5 | − 54.7 | 948,803 | 32 | − 55.1 |
Other malignant neoplasms | 141,110 | 4.8 | 28 | 51,453 | 1.7 | 2.3 | 3,230,198 | 109.1 | 3.3 |
Other pharynx cancer | 7103 | 0.3 | 36.5 | 4360 | 0.2 | 21.6 | 244,994 | 10.4 | 21.8 |
Ovarian cancer | 35,831 | 1.2 | 30.9 | 8896 | 0.3 | 12.8 | 529,030 | 17.6 | 13.8 |
Pancreatic cancer | 9401 | 0.3 | 18.2 | 7609 | 0.3 | 16.2 | 420,797 | 13.9 | 16 |
Prostate cancer | 5472 | 0.2 | 77.9 | 876 | 0 | − 0.7 | 54,331 | 2.3 | 2.8 |
Stomach cancer | 49,008 | 1.6 | − 30.9 | 27,895 | 0.9 | − 46.8 | 1,573,897 | 52 | − 46.4 |
Testicular cancer | 57,401 | 1.9 | 42 | 5352 | 0.2 | − 3.9 | 349,083 | 11.7 | − 0.6 |
Thyroid cancer | 46,832 | 1.6 | 65.8 | 2853 | 0.1 | − 0.6 | 190,923 | 6.4 | 4.7 |
Tracheal, bronchus, and lung cancer | 32,601 | 1.1 | − 24.1 | 24,772 | 0.8 | − 29.4 | 1,386,001 | 45.8 | − 29 |
Uterine cancer | 19,415 | 0.8 | 14.9 | 1808 | 0.1 | − 37.8 | 110,215 | 4.7 | − 35 |